WHO ICTRP trial
The effect of methylprednisolone on the neuromuscular blockade reversal effect…
KCT0002239 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0002239 |
|---|---|
| Public title | The effect of methylprednisolone on the neuromuscular blockade reversal effect of sugammadex |
| Scientific title | The effect of methylprednisolone on the neuromuscular blockade reversal effect of sugammadex |
| Primary sponsor | Bundang CHA General Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Not Applicable |
| Interventions | Drug : At present, the decision to administer methyprednisolone is done by a neurosurgeon considering the size of the tumor and the possiblitiy of adrenal crisis. Therefore, patients will be divided into two groups, methylprednisolone… |
| Registration date | Feb 22, 2017 |
| Target size | 30 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: